Company / Operating Income per Share
Dyne Therapeutics, Inc. Operating Income per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.36
FY2024
5-year range
-$4.07 / -$2.95
FY2020-FY2024
Trend
+14.7%
vs FY2023
Sector context
#144 of 199
Health Care
What the data says
At $-3.36, Dyne Therapeutics, Inc.'s operating income per share ranks #144 of 199 in the Health Care sector. Operating Income per Share returned to growth in FY2024 after 2 years of decline, reaching $-3.36.
Based on SEC 10-K filings.
-3.36 in FY2024.
Declined from $-3.07 to $-3.36 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
In line with sector averageTop 72% of 199This company -$3.36 Sector average -$3.34
▼
In line with sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 14.7% year-over-year.
- Ranks #144 out of 199 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.36 | +14.7% |
| FY2023 | -$3.94 | -28.2% |
| FY2022 | -$3.07 | -4.2% |
| FY2021 | -$2.95 | +27.6% |
| FY2020 | -$4.07 | +28.0% |
| FY2019 | -$5.66 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026